Pfizer Inc. (NEO: PFE)

Market Cap	228.60B
Revenue (ttm)	75.50B
Net Income (ttm)	-3.55B
Shares Out	n/a
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,612
Open	13.58
Previous Close	13.65
Day's Range	13.56 - 13.62
52-Week Range	11.83 - 14.83
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and po...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 88,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: PFE

Financial Performance

In 2023, Pfizer's revenue was $58.50 billion, a decrease of -41.70% compared to the previous year's $100.33 billion. Earnings were $2.12 billion, a decrease of -93.25%.

Financial numbers in USD